Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Big Pharma Is Back In The M&A Driver’s Seat For 2017

Jan 09 2017

• By Jessica Merrill

business card

Related Content

Teva Gets What It Wants – Allergan Generics, Not Mylan

Aug 03 2015

After A Gargantuan Year For Pharma M&A, More To Come In 2015

Jan 12 2015

Pharma Is Ready And Waiting For A Tax Holiday Under Trump

Nov 09 2016

Meet The New $200bn Normal In M&A, Says EY

Jan 11 2016

Was Sanofi’s Offer One That Actelion Could Refuse? J&J Back At Bargaining Table

Dec 22 2016

Pfizer’s $14bn Medivation Buyout Shows How Far Pharma Will Go In Oncology

Aug 22 2016

Related Companies

Allergan plc

Bausch Health Companies Inc.

Endo, Inc.

Teva Pharmaceutical Industries Ltd.

Bristol Myers Squibb Company

AbbVie Inc.

AstraZeneca PLC

Novartis AG

Johnson & Johnson

Merck & Co., Inc.

Actelion Pharmaceuticals Ltd.

Bayer AG

Monsanto Company

Takeda Pharmaceutical Co. Ltd.

Baxter International Inc.

Baxalta Incorporated

Pfizer Inc.

Medivation, Inc.

Additional Topics

M & A Deals Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window